Lupin launches nasal spray in US, part of 200-drug pipeline by FY30
  Lupin rolls out Nasal spray for rhinorrhea relief in US
  Lupin launches Ipratropium Bromide nasal spray in US
  Lupin launches generic version of anticholinergic medication Ipratropium bromide in United States
  Lupin stock gains after pharma major carves out consumer healthcare unit
  Lupin introduces ipratropium bromide nasal solution, 0.03% ' 0.06% in US markets
  Lupin carves out consumer healthcare business
  Lupin carves out consumer healthcare biz into wholly owned subsidiary